Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1981 Jan 31;282(6261):343–346. doi: 10.1136/bmj.282.6261.343

Psoriasis and its treatment.

R H Champion
PMCID: PMC1504166  PMID: 6780018

Full text

PDF
343

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atherton D. J., Wells R. S., Laurent M. R., Williams Y. F. Razoxane (ICRF 159) in the treatment of psoriasis. Br J Dermatol. 1980 Mar;102(3):307–317. doi: 10.1111/j.1365-2133.1980.tb08145.x. [DOI] [PubMed] [Google Scholar]
  2. Baker H. Psoriasis--clinical features. Br Med J. 1971 Jul 24;3(5768):231–233. doi: 10.1136/bmj.3.5768.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baker H. Psoriasis: a review. Part I. Dermatologica. 1975;150(1):16–25. [PubMed] [Google Scholar]
  4. Bridges B., Strauss G. Possible hazards of photochemotherapy for psoriasis. Nature. 1980 Feb 7;283(5747):523–524. doi: 10.1038/283523a0. [DOI] [PubMed] [Google Scholar]
  5. Briffa D. V., Warin A. P. Photochemotherapy in psoriasis: a review. J R Soc Med. 1979 Jun;72(6):440–446. doi: 10.1177/014107687907200610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dahl M. G., Gregory M. M., Scheuer P. J. Liver damage due to methotrexate in patients with psoriasis. Br Med J. 1971 Mar 20;1(5750):625–630. doi: 10.1136/bmj.1.5750.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dahl M. G., Gregory M. M., Scheuer P. J. Methotrexate hepatotoxicity in psoriasis--comparison of different dose regimens. Br Med J. 1972 Mar 11;1(5801):654–656. doi: 10.1136/bmj.1.5801.654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dahl M. V., Lindroos W. E., Nelson R. D. Chemokinetic and chemotactic factors in psoriasis scale extracts. J Invest Dermatol. 1978 Dec;71(6):402–406. doi: 10.1111/1523-1747.ep12558281. [DOI] [PubMed] [Google Scholar]
  9. Dobson R. L. The inheritance of psoriasis. Arch Dermatol. 1980 Jun;116(6):657–657. [PubMed] [Google Scholar]
  10. Dubertret L., Averbeck D., Zajdela F., Bisagni E., Moustacchi E., Touraine R., Latarjet R. Photochemotherapy (PUVA) of psoriasis using 3-carbethoxypsoralen, a non-carcinogenic compound in mice. Br J Dermatol. 1979 Oct;101(4):379–389. doi: 10.1111/j.1365-2133.1979.tb00015.x. [DOI] [PubMed] [Google Scholar]
  11. Farber E. M., Nall M. L. The natural history of psoriasis in 5,600 patients. Dermatologica. 1974;148(1):1–18. doi: 10.1159/000251595. [DOI] [PubMed] [Google Scholar]
  12. Farber E. M., Pearlman D., Abel E. A. An appraisal of current systemic chemotherapy for psoriasis. Arch Dermatol. 1976 Nov 29;112(Spec No):1679–1688. doi: 10.1001/archderm.1976.01630360047013. [DOI] [PubMed] [Google Scholar]
  13. Fisher L. B., Maibach H. I. The effect of anthralin and its derivatives on epidermal cell kinetics. J Invest Dermatol. 1975 May;64(5):338–341. doi: 10.1111/1523-1747.ep12512282. [DOI] [PubMed] [Google Scholar]
  14. Frosch P. J., Behrenbeck E. M., Frosch K., Macher E. The Duhring chamber assay for corticosteroid atrophy. Br J Dermatol. 1981 Jan;104(1):57–65. doi: 10.1111/j.1365-2133.1981.tb01712.x. [DOI] [PubMed] [Google Scholar]
  15. Grove G. L. Epidermal cell kinetics in psoriasis. Int J Dermatol. 1979 Mar;18(2):111–122. doi: 10.1111/j.1365-4362.1979.tb04486.x. [DOI] [PubMed] [Google Scholar]
  16. Hardie R. A., Hunter A. A. Dermatology: psoriasis. Br J Hosp Med. 1978 Jul;20(1):13–23. [PubMed] [Google Scholar]
  17. Hönigsmann H., Jaschke E., Gschnait F., Brenner W., Fritsch P., Wolff K. 5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasis. Br J Dermatol. 1979 Oct;101(4):369–378. doi: 10.1111/j.1365-2133.1979.tb00014.x. [DOI] [PubMed] [Google Scholar]
  18. Hönigsmann H., Wolff K., Gschnait F., Brenner W., Jaschke E. Keratoses and nonmelanoma skin tumors in long-term photochemotherapy (PUVA). J Am Acad Dermatol. 1980 Oct;3(4):406–414. doi: 10.1016/s0190-9622(80)80336-7. [DOI] [PubMed] [Google Scholar]
  19. INGRAM J. T. The significance and management of psoriasis. Br Med J. 1954 Oct 9;2(4892):823–828. doi: 10.1136/bmj.2.4892.823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lazarus G. S., Gilgor R. S. Psoriasis, polymorphonuclear leukocytes, and lithium carbonate. An important clue. Arch Dermatol. 1979 Oct;115(10):1183–1184. [PubMed] [Google Scholar]
  21. Lesiewicz J., Goldsmith L. A. Ornithine decarboxylase in skin. J Invest Dermatol. 1980 Sep;75(3):207–210. doi: 10.1111/1523-1747.ep12522885. [DOI] [PubMed] [Google Scholar]
  22. Mali J. W. Psoriasis: a dynamic disease. Br J Dermatol. 1979 Dec;101(6):725–730. doi: 10.1111/j.1365-2133.1979.tb05655.x. [DOI] [PubMed] [Google Scholar]
  23. Michaëlsson G. Increased chemotactic activity of neutrophil leukocytes in psoriasis. Br J Dermatol. 1980 Oct;103(4):351–356. doi: 10.1111/j.1365-2133.1980.tb07256.x. [DOI] [PubMed] [Google Scholar]
  24. Mier P. D., Gommans J. M., Roelfzema H. On the aetiology of psoriasis. Br J Dermatol. 1980 Oct;103(4):457–460. doi: 10.1111/j.1365-2133.1980.tb07272.x. [DOI] [PubMed] [Google Scholar]
  25. Orenberg E. K., Deneau D. G., Farber E. M. Response of chronic psoriatic plaques to localized heating induced by ultrasound. Arch Dermatol. 1980 Aug;116(8):893–897. [PubMed] [Google Scholar]
  26. Orfanos C. E. Oral retinoids--present status. Br J Dermatol. 1980 Nov;103(5):473–481. doi: 10.1111/j.1365-2133.1980.tb01661.x. [DOI] [PubMed] [Google Scholar]
  27. Parrish J. A., Fitzpatrick T. B., Tanenbaum L., Pathak M. A. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med. 1974 Dec 5;291(23):1207–1211. doi: 10.1056/NEJM197412052912301. [DOI] [PubMed] [Google Scholar]
  28. Peck G. L., Olsen T. G., Yoder F. W., Strauss J. S., Downing D. T., Pandya M., Butkus D., Arnaud-Battandier J. Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid. N Engl J Med. 1979 Feb 15;300(7):329–333. doi: 10.1056/NEJM197902153000701. [DOI] [PubMed] [Google Scholar]
  29. Peck G. L. Retinoids in dermatology: an interim report. Arch Dermatol. 1980 Mar;116(3):283–284. [PubMed] [Google Scholar]
  30. Perlman S. G., Gerber L. H., Roberts R. M., Nigra T. P., Barth W. F. Photochemotherapy and psoriatic arthritis. A prospective study. Ann Intern Med. 1979 Nov;91(5):717–722. doi: 10.7326/0003-4819-91-5-717. [DOI] [PubMed] [Google Scholar]
  31. Petrozzi J. W., Barton J. O., Kaidbey K. K., Kligman A. M. Updating the Goeckerman regimen for psoriasis. Br J Dermatol. 1978 Apr;98(4):437–444. doi: 10.1111/j.1365-2133.1978.tb06538.x. [DOI] [PubMed] [Google Scholar]
  32. Robinson J. K., Baughman R. D., Auerbach R., Cimis R. J. Methotrexate hepatotoxicity in psoriasis. Consideration of liver biopsies at regular intervals. Arch Dermatol. 1980 Apr;116(4):413–415. doi: 10.1001/archderm.116.4.413. [DOI] [PubMed] [Google Scholar]
  33. Shuster S., Chapman P. H., Rawlins M. D. Psoriasis and cancer. Br Med J. 1979 Apr 7;1(6168):941–942. doi: 10.1136/bmj.1.6168.941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Skoven I., Thormann J. Lithium compound treatment and psoriasis. Arch Dermatol. 1979 Oct;115(10):1185–1187. [PubMed] [Google Scholar]
  35. Stern R. S., Thibodeau L. A., Kleinerman R. A., Parrish J. A., Fitzpatrick T. B. Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Engl J Med. 1979 Apr 12;300(15):809–813. doi: 10.1056/NEJM197904123001501. [DOI] [PubMed] [Google Scholar]
  36. Suader D. N., Bailin P. L., Sundeen J., Krakauer R. S. Suppressor cell function in psoriasis. Arch Dermatol. 1980 Jan;116(1):51–55. doi: 10.1001/archderm.116.1.51. [DOI] [PubMed] [Google Scholar]
  37. Summer W. Photo-carcinogenicity: the physical basis of its exogenous causes. Br J Dermatol. 1980 May;102(5):611–619. doi: 10.1111/j.1365-2133.1980.tb07665.x. [DOI] [PubMed] [Google Scholar]
  38. Voorhees J. J. Polyamines and psoriasis. Arch Dermatol. 1979 Aug;115(8):943–944. [PubMed] [Google Scholar]
  39. Wahba A., Cohen H. A., Bar-Eli M., Gallily R. Enhanced chemotactic and phagocytic activities of leukocytes in psoriasis vulgaris. J Invest Dermatol. 1978 Sep;71(3):186–188. doi: 10.1111/1523-1747.ep12547117. [DOI] [PubMed] [Google Scholar]
  40. Wahba A. Immunological alterations in psoriasis. Int J Dermatol. 1980 Apr;19(3):124–129. doi: 10.1111/j.1365-4362.1980.tb00274.x. [DOI] [PubMed] [Google Scholar]
  41. Weinstein G. D. Methotrexate. Ann Intern Med. 1977 Feb;86(2):199–204. doi: 10.7326/0003-4819-86-2-199. [DOI] [PubMed] [Google Scholar]
  42. Wolff K. W., Fitzpatrick T. B., Parrish J. A., Gschnait F., Gilchrest B., Hönigsmann H., Pathak M. A., Tannenbaum L. Photochemotherapy for psoriasis with orally administered methoxsalen. Arch Dermatol. 1976 Jul;112(7):943–950. [PubMed] [Google Scholar]
  43. van Weelden H., Young E., van der Leun J. C. Therapy of psoriasis: comparison of photochemotherapy and several variants of phototherapy. Br J Dermatol. 1980 Jul;103(1):1–9. doi: 10.1111/j.1365-2133.1980.tb15831.x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES